T2	control 706 727	standard chemotherapy
T1	intervention 118 158	chemotherapy with or without trastuzumab
T3	total-participants 881 885	2318
T5	outcome 1364 1385	disease-free survival
T4	outcome 1613 1625	sHER2 levels
T6	outcome 1790 1815	survival after recurrence
T7	outcome 1823 1851	3-year overall survival rate
